Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage
- Conditions
- Vitreous HemorrhageDiabetic Retinopathy
- Interventions
- Drug: Placebo
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2013-03-15
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 510
- Registration Number
- NCT00198497
- Locations
- ๐ฆ๐บ
Royal North Shore Hospital, St. Leonards, New South Wales, Australia
๐ฆ๐บUniversity of Sydney, Sydney, New South Wales, Australia
๐ฆ๐บUniversity of Sydney/Westmead Hospital, Westmead, New South Wales, Australia
Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome
- Conditions
- Dry Eye Syndromes
- Interventions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2013-03-14
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 159
- Registration Number
- NCT00198536
- Locations
- ๐บ๐ธ
Central Maine Eye Care, Lewiston, Maine, United States
๐บ๐ธAndover Eye Associates, Andover, Massachusetts, United States
๐บ๐ธEyesight Ophthalmic Services, PA, Dover, New Hampshire, United States
Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2013-03-14
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 65
- Registration Number
- NCT00198419
- Locations
- ๐บ๐ธ
Solano Clinical Research (A Division of Dow Pharmaceutical Sciences), Davis, California, United States
Evaluation of Vitrase as a Spreading Agent
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2013-03-14
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 108
- Registration Number
- NCT00198484
- Locations
- ๐บ๐ธ
David Wirta, MD, Inc., Newport Beach, California, United States
๐บ๐ธRichard A Lewis, MD, Sacramento, California, United States
๐บ๐ธE Randy Craven, MD, Littleton, Colorado, United States
Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery
- Conditions
- Postoperative ComplicationsCataract
- Interventions
- Drug: Placebo
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2013-03-14
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 527
- Registration Number
- NCT00198445
- Locations
- ๐บ๐ธ
Harold A Helms, MD, Birmingham, Alabama, United States
๐บ๐ธEye Care Arkansas, PA, Little Rock, Arkansas, United States
๐บ๐ธUCI, Department of Ophthalmology, Irvine, California, United States